Needham, MA, United States of America

Jason Baum

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Jason Baum: Innovator in Antibody Development

Introduction

Jason Baum, an accomplished inventor based in Needham, MA, has made significant strides in the field of biopharmaceuticals. With four patents to his name, he focuses on the development of innovative antibodies that have the potential to impact cancer therapies.

Latest Patents

His most recent patents include the creation of monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies. These antibodies serve as anti-neoplastic agents, specifically binding to human IGF-1R and human ErbB3. The exemplary antibodies are designed to inhibit signal transduction through either or both IGF-1R and ErbB3, showcasing their versatility and therapeutic potential. Furthermore, these proteins consist of at least one binding site for anti-IGF-1R and at least one for anti-ErbB3, which may be connected via an immunoglobulin constant region.

Career Highlights

Jason Baum currently works at Merrimack Pharmaceuticals, Inc., where his expertise in antibody development is invaluable. His research focuses on creating cutting-edge therapeutic options that can effectively combat cancer by disrupting critical signaling pathways involved in tumor growth.

Collaborations

Collaboration is key in the innovative landscape, and Baum works closely with notable colleagues Bryan Johnson and Alexey Alexandrovich Lugovskoy. Together, they contribute to the advancement of their firm's research initiatives and push the boundaries of oncological therapies.

Conclusion

Jason Baum exemplifies the spirit of innovation with his groundbreaking work in antibody development. His patents reflect a commitment to improving cancer treatment and enhancing therapeutic options available to patients. As he continues to collaborate with talented peers, the potential for his work to make a profound impact in medical science remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…